Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totaling 1,929 shares, a drop of 87.4% from the August 15th total of 15,265 shares. Based on an average daily trading volume, of 183,762 shares, the days-to-cover ratio is currently 0.0 days.
Sinopharm Group Price Performance
Shares of Sinopharm Group stock opened at $9.69 on Friday. The firm has a 50-day moving average of $10.60 and a 200-day moving average of $11.57. Sinopharm Group has a 52-week low of $9.54 and a 52-week high of $14.87.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
Featured Stories
- Five stocks we like better than Sinopharm Group
- Copper’s Record Rally Highlights a Deeper Supply Problem
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
